Literature DB >> 15149331

In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection.

Griet L Glorieux1, Annemieke W Dhondt, Peter Jacobs, Joke Van Langeraert, Norbert H Lameire, Peter Paul De Deyn, Raymond C Vanholder.   

Abstract

BACKGROUND: The blunted immune response upon stimulation in chronic renal failure (CRF) is often coupled to a baseline inflammatory status which has been related to atherogenesis. Uremic biologic fluids and several specific uremic retention solutes alter cell-mediated immune responses, as well as the interaction of calcitriol with the immune system.
METHODS: The present study evaluated the influence of different guanidino compounds on DNA synthesis, chemiluminescence production, and CD14 expression of undifferentiated and calcitriol-differentiated HL-60 cells. In a second setup, these guanidino compounds were evaluated for their specific effect on normal human leukocyte oxidative burst activity and tumor necrosis factor-alpha (TNF-alpha) expression.
RESULTS: First, several guanidino compounds elicited proinflammatory effects on leukocytes. Methylguanidine and guanidine stimulated the proliferation of undifferentiated HL-60 cells and the antiproliferative effect of calcitriol (P < 0.05) was neutralized in the presence of methylguanidine (P < 0.05) and guanidinosuccinic acid (P < 0.05). The phorbol-myristate-acetate (PMA)-stimulated chemiluminescence production of the calcitriol differentiated HL-60 cells was enhanced in the presence of guanidine (P < 0.05). Methylguanidine and guanidinoacetic acid enhanced the lipopolysaccharide (LPS)-stimulated intracellular production of TNF-alpha by normal human monocytes (P < 0.05). Second, several guanidino compounds inhibited the function of leukocytes if they were activated. The PMA-stimulated chemiluminescence production of the calcitriol differentiated HL-60 cells was inhibited by the presence of methylguanidine (P < 0.05), guanidinoacetic acid (P < 0.05) and guanidinosuccinic acid (P < 0.05). After incubation of whole blood in the presence of methylguanidine, the Escherichia coli stimulated oxidative burst activity of the granulocyte population was significantly inhibited (P < 0.05). In addition, guanidinosuccinic acid had an inhibitory effect on the LPS-stimulated intracellular production of TNF-alpha by human monocytes (P < 0.01).
CONCLUSION: Guanidino compounds exert proinflammatory as well as anti-inflammatory effects on monocyte/macrophage function. This could contribute to the altered prevalence of cardiovascular disease and propensity to infection in patients with CRF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149331     DOI: 10.1111/j.1523-1755.2004.00631.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  24 in total

1.  Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease.

Authors:  Eva Schepers; Daniela V Barreto; Sophie Liabeuf; Griet Glorieux; Sunny Eloot; Fellype C Barreto; Ziad Massy; Raymond Vanholder
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-04       Impact factor: 8.237

Review 2.  Challenges and opportunities for stem cell therapy in patients with chronic kidney disease.

Authors:  LaTonya J Hickson; Alfonso Eirin; Lilach O Lerman
Journal:  Kidney Int       Date:  2016-01-26       Impact factor: 10.612

Review 3.  An update on uremic toxins.

Authors:  N Neirynck; R Vanholder; E Schepers; S Eloot; A Pletinck; G Glorieux
Journal:  Int Urol Nephrol       Date:  2012-08-15       Impact factor: 2.370

4.  Considerations in the statistical analysis of hemodialysis patient survival.

Authors:  Christos Argyropoulos; Chung-Chou H Chang; Laura Plantinga; Nancy Fink; Neil Powe; Mark Unruh
Journal:  J Am Soc Nephrol       Date:  2009-07-30       Impact factor: 10.121

5.  Cationic uremic toxins affect human renal proximal tubule cell functioning through interaction with the organic cation transporter.

Authors:  Carolien M S Schophuizen; Martijn J Wilmer; Jitske Jansen; Lena Gustavsson; Constanze Hilgendorf; Joost G J Hoenderop; Lambert P van den Heuvel; Rosalinde Masereeuw
Journal:  Pflugers Arch       Date:  2013-06-29       Impact factor: 3.657

6.  Elimination of endogenous toxin, creatinine from blood plasma depends on albumin conformation: site specific uremic toxicity & impaired drug binding.

Authors:  Ankita Varshney; Mohd Rehan; Naidu Subbarao; Gulam Rabbani; Rizwan Hasan Khan
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

7.  Uremic Toxins Induce ET-1 Release by Human Proximal Tubule Cells, which Regulates Organic Cation Uptake Time-Dependently.

Authors:  Carolien M S Schophuizen; Joost G J Hoenderop; Rosalinde Masereeuw; Lambert P van den Heuvel
Journal:  Cells       Date:  2015-06-26       Impact factor: 6.600

Review 8.  Immune dysfunction in uremia&#8212;an update.

Authors:  Gerald Cohen; Walter H Hörl
Journal:  Toxins (Basel)       Date:  2012-10-24       Impact factor: 4.546

Review 9.  What is new in uremic toxicity?

Authors:  Raymond Vanholder; Steven Van Laecke; Griet Glorieux
Journal:  Pediatr Nephrol       Date:  2008-03-07       Impact factor: 3.714

10.  Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacy.

Authors:  Griet Glorieux; James Tattersall
Journal:  Clin Kidney J       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.